2289.HK Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (19 Apr 2024 @ 03:01):

Stats
Today's Volume	209 000
Average Volume	147 241
Market Cap	1.08B
EPS	HKD0 ( 2024-03-29 )
Last Dividend	HKD0.499 ( 2023-06-29 )
Next Dividend	HKD0 ( N/A )
P/E	19.57
ATR14	HKD0 (0.00%)

Charmacy Pharmaceutical Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Charmacy Pharmaceutical Financials

Annual	2022
Revenue:	HKD4.18B
Gross Profit:	HKD268.61M (6.43 %)
EPS:	HKD0.840

Q2	2023
Revenue:	HKD2.27B
Gross Profit:	HKD138.71M (6.11 %)
EPS:	HKD0.240

Q4	2022
Revenue:	HKD2.29B
Gross Profit:	HKD147.08M (6.43 %)
EPS:	HKD0.650

Q2	2022
Revenue:	HKD1.89B
Gross Profit:	HKD121.53M (6.44 %)
EPS:	HKD0.190

Financial Reports:

No articles found.

Charmacy Pharmaceutical Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0.949 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)

Charmacy Pharmaceutical Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 3.61 - low (20.14%) | Divividend Growth Potential Score: 2.86 - Decrease likely (42.83%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	HKD0.229	2016-11-14
Last Dividend	HKD0.499	2023-06-29
Next Dividend	HKD0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	9	--
Total Paid Out	HKD2.57	--
Avg. Dividend % Per Year	0.00%	--
Score	1.56	--
Div. Sustainability Score	3.61
Div.Growth Potential Score	2.86
Div. Directional Score	3.23	--

Next Divdend (Est)
(2024-10-07)

HKD0.572 Estimate 3.10 %

Dividend Stability

0.25 Very Poor

Dividend Score

1.56

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for HKSE

Symbol	Title	Last dividend	Frequency	Yearly Dividend
6886.HK	Ex Dividend Junior	2023-07-12	Annually	0.00%
1982.HK	Ex Dividend Junior	2023-07-06	Annually	0.00%
1051.HK	Ex Dividend Junior	2023-06-26	Sporadic	0.00%
0133.HK	Ex Dividend Junior	2023-06-01	Annually	0.00%
3393.HK	Ex Dividend Knight	2023-05-18	Annually	0.00%
1599.HK	Ex Dividend Junior	2023-05-31	Annually	0.00%
0639.HK	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
9922.HK	Ex Dividend Junior	2023-06-07	Annually	0.00%
2182.HK	Ex Dividend Knight	2023-06-12	Annually	0.00%
1184.HK	Ex Dividend Knight	2023-09-21	Semi-Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0211	1.500	9.58	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0339	1.200	8.87	10.00	[0 - 0.3]
returnOnEquityTTM	0.165	1.500	9.28	10.00	[0.1 - 1]
payoutRatioTTM	0.268	-1.000	7.32	-7.32	[0 - 1]
currentRatioTTM	1.076	0.800	9.62	7.69	[1 - 3]
quickRatioTTM	0.587	0.800	-1.250	-1.000	[0.8 - 2.5]
cashRatioTTM	0.198	1.500	-0.0103	-0.0154	[0.2 - 2]
debtRatioTTM	0.486	-1.500	1.892	-2.84	[0 - 0.6]
interestCoverageTTM	0	1.000	-1.111	-1.111	[3 - 30]
operatingCashFlowPerShareTTM	-1.419	2.00	-0.473	-0.946	[0 - 30]
freeCashFlowPerShareTTM	-1.755	2.00	-0.878	-1.755	[0 - 20]
debtEquityRatioTTM	2.41	-1.500	0.375	-0.563	[0 - 2.5]
grossProfitMarginTTM	0.0627	1.000	-2.29	-2.29	[0.2 - 0.8]
operatingProfitMarginTTM	0.0221	1.000	-1.558	-1.558	[0.1 - 0.6]
cashFlowToDebtRatioTTM	-0.111	1.000	-1.729	-1.729	[0.2 - 2]
assetTurnoverTTM	1.609	0.800	2.61	2.09	[0.5 - 2]
Total Score				3.61

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	10.50	1.000	9.04	0	[1 - 100]
returnOnEquityTTM	0.165	2.50	9.54	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	-1.755	2.00	-0.585	-1.755	[0 - 30]
dividendYielPercentageTTM	10.16	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	-1.419	2.00	-0.473	-0.946	[0 - 30]
payoutRatioTTM	0.268	1.500	7.32	-7.32	[0 - 1]
pegRatioTTM	0	1.500	-3.33	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	-0.0336	1.000	-3.34	0	[0.1 - 0.5]
Total Score				2.86

Charmacy Pharmaceutical

Charmacy Pharmaceutical Co., Ltd. engages in the trading of pharmaceutical products in the People's Republic of China. The company offers western medicines, Chinese patent medicines, healthcare products, and related consulting services to downstream distributors and terminal chemists. It also operates Charmacy e-Medicine, a B2B e-commerce platform to place orders online and make inquiries and payments. The company was formerly known as Chuangmei Pharmaceutical Co., Ltd. and changed its name to Charmacy Pharmaceutical Co., Ltd. in July 2016. Charmacy Pharmaceutical Co., Ltd. was incorporated in 1984 and is headquartered in Shantou, the People's Republic of China.